Protalix BioTherapeutics, Inc.
PLXAMEXHealthcare● Active
$1.96
$-0.03(-1.51%)
Market Cap$157920418
P/E Ratio—
52W High$3.19
52W Low$1.32
Protalix BioTherapeutics, Inc. (PLX) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PLX · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $30.27M | $34.83M | $44.56M | $22.18M | $38.98M |
| Net Receivables | $8.84M | $2.91M | $5.27M | $4.59M | $3.44M |
| Inventory | $25.73M | $21.24M | $19.05M | $16.80M | $17.95M |
| Total Current Assets | $66.67M | $60.08M | $69.93M | $44.88M | $61.67M |
| PP&E Net | $12.58M | $10.02M | $10.88M | $9.64M | $9.92M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $82.35M | $73.42M | $84.43M | $55.79M | $73.67M |
| Liabilities | |||||
| Short-Term Debt | $0.00M | $0.00M | $21.66M | $0.00M | $0.00M |
| Accounts Payable | $5.26M | $4.53M | $4.32M | $5.86M | $6.99M |
| Total Current Liabilities | $26.52M | $25.62M | $45.53M | $32.43M | $33.18M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $28.19M | $27.89M |
| Total Liabilities | $34.12M | $30.21M | $50.87M | $66.43M | $79.70M |
| Stockholders Equity | |||||
| Retained Earnings | ($385.00M) | ($378.39M) | ($381.55M) | ($389.86M) | ($374.93M) |
| Total Stockholders Equity | $48.23M | $43.21M | $33.57M | ($10.64M) | ($6.04M) |
| Total Liab & Equity(computed) | $82.35M | $73.42M | $84.43M | $55.79M | $73.67M |
| Debt Summary | |||||
| Total Debt | $8.32M | $5.53M | $27.69M | $33.47M | $33.47M |
| Net Debt | ($6.36M) | ($14.23M) | $4.06M | $16.36M | ($5.51M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Protalix BioTherapeutics, Inc. data
About Protalix BioTherapeutics, Inc. (PLX) Balance Sheet
Protalix BioTherapeutics, Inc. (PLX) balance sheet shows total assets of $0.08B with cash of $0.03B. Total liabilities are $0.03B, total debt $0.01B, and stockholders equity $0.05B.
Frequently asked questions
PLX · 4 questionsProtalix BioTherapeutics, Inc. has total debt of $0.01B with net debt of ($0.01B).
PLX total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10